Alpha-GPC vs Phosphatidylserine: Which Is Better for Cognitive Performance?

Two of the most-studied cognitive support compounds are Alpha-GPC and phosphatidylserine. They're often discussed as alternatives, but they actually work through different mechanisms and serve different purposes. Here's a precise comparison.

How Alpha-GPC Works

Alpha-GPC (L-Alpha-Glycerylphosphorylcholine) is a choline precursor that crosses the blood-brain barrier efficiently. Once across, it's converted to acetylcholine — the neurotransmitter most associated with memory, attention, and learning.

Human trials (Rondanelli 2016; De Jesus Moreno 2003, PMID: 12637119) have shown improvements in cognitive function scores. Athletes have also used it for power output (Bellar 2015 showed increased peak force production after Alpha-GPC supplementation).

How Phosphatidylserine Works

Phosphatidylserine (PS) is a phospholipid that's a structural component of neuronal cell membranes. It supports membrane fluidity, signaling, and neurotransmitter release — without directly increasing any single neurotransmitter.

Research (Cenacchi 1993, multi-center; Kim et al. 2021) suggests PS supports cognitive function in age-related cognitive decline. Some studies indicate it modulates cortisol response to acute stress, which is relevant for performance under pressure.

Head-to-Head: Mechanism Comparison

Alpha-GPC: upstream neurotransmitter precursor → acute acetylcholine boost. Phosphatidylserine: structural support of all neurons → systemic membrane health. They are not competing — they address different layers.

When to Use Alpha-GPC

For acute cognitive demand: 30 minutes before deep work, important meetings, or training requiring fine motor coordination. Doses in studies range 300–600mg.

When to Use Phosphatidylserine

For consistent daily cognitive support, particularly for adults focused on long-term cognitive health or those under sustained stress. Common doses: 100–300mg/day with food.

Can You Stack Them?

Yes. They have different mechanisms and no contraindicated interaction. MYKO Drive combines Alpha-GPC + Phosphatidylserine 20% in a single capsule designed for pre-deep-work timing.

The Bottom Line

Don't pick one over the other. Use Alpha-GPC for acute performance moments and stack PS daily for membrane-level support. The two compounds address different layers of cognitive function.

Frequently Asked Questions

Can I take both Alpha-GPC and Phosphatidylserine?

Yes. They work through different mechanisms with no contraindication. MYKO Drive includes both in a single capsule.

Which works faster?

Alpha-GPC has acute effects within 30–60 minutes (acetylcholine boost). Phosphatidylserine works cumulatively over weeks (membrane-level support). Different timelines for different jobs.

What's the right dose?

Studies use 300–600mg Alpha-GPC and 100–300mg PS. MYKO Drive's per-capsule amounts fit research-supported daily protocols.

Side effects?

Both compounds have excellent safety profiles. Alpha-GPC can rarely cause mild headache at high doses (>1200mg). PS has no documented common side effects at standard doses.

The Practical Protocol

• Pre-deep work: MYKO Drive 30 min before
• Daily PS support: Continuous via MYKO Drive routine use
• Cycle: No cycling required for either compound
• Pair with: Lion's Mane (Clarity) for neuroplasticity layer

References:
De Jesus Moreno M (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate. Clinical Therapeutics. PMID: 12637119
Cenacchi T, et al. (1993). Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging. PMID: 8323999
Bellar D, et al. (2015). The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of the International Society of Sports Nutrition. PMID: 26525142

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.